Rare emm6.10 Streptococcus pyogenes Causing an Unusual Invasive Infection in a Child: Clinical and Genomic Insights
Open Access
- 29 October 2025
- journal article
- case report
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2475
Abstract
Invasive group A streptococcal (iGAS) infections are increasingly recognized as a global public health concern, with a notable resurgence observed among pediatric populations in high-income countries following the relaxation of COVID-19-related restrictions. While the most commonly implicated emm types in invasive disease are emm1 and emm3, the global distribution of Streptococcus pyogenes strains is highly diverse, posing challenges for surveillance and vaccine development. We describe a 3-year-old boy with a femoral subperiosteal abscess, a rare clinical manifestation of iGAS, caused by an emm6.10 S. pyogenes strain. The diagnosis was confirmed by positive blood cultures and magnetic resonance imaging. Antibiotic therapy included intravenous ceftriaxone followed by oral amoxicillin, and then prolonged oral clindamycin was introduced due to the deep-seated nature of the infection. Molecular typing was performed by the national reference center as part of routine surveillance of invasive strains. This case emphasizes the importance of recognizing atypical clinical presentations of iGAS in children and the crucial role of strain typing in epidemiological monitoring. It also illustrates how the remarkable emm-type diversity of S. pyogenes remains a major obstacle to effective vaccine design, despite ongoing efforts with multivalent M-protein-based candidates and alternative strategies targeting conserved antigens. Enhanced global surveillance and inclusive vaccine design are urgently needed to address the full spectrum of circulating GAS strains.Keywords
This publication has 31 references indexed in Scilit:
- Invasive group A streptococcal infections: lessons learned from the 2022–23 upsurgeThe Lancet Infectious Diseases, 2025
- M1 and done? Global assessment of the invasive potential of group A streptococcal strainsThe Lancet Microbe, 2025
- Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic reviewThe Lancet Microbe, 2023
- Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005–2020European Journal of Clinical Microbiology & Infectious Diseases, 2023
- Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019–2022The Lancet Regional Health - Europe, 2023
- Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007–2019European Journal of Clinical Microbiology & Infectious Diseases, 2021
- Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyThe Lancet Infectious Diseases, 2019
- Status of research and development of vaccines for Streptococcus pyogenesVaccine, 2016
- Lytic rib lesion in a 1-year-old child: group A beta streptococcal osteomyelitis mimicking tumorPediatric Surgery International, 2006
- The global burden of group A streptococcal diseasesThe Lancet Infectious Diseases, 2005